Chapter 4 - Endocrine, nutritional and metabolic diseases (E00-E89)»Diabetes mellitus (E08-E13)»Type 2 diabetes mellitus (E11)
E11
Type 2 diabetes mellitus
Sub-codes (9)
- E11.0 Type 2 diabetes mellitus with hyperosmolarity
- E11.1 Type 2 diabetes mellitus with ketoacidosis
- E11.2 Type 2 diabetes mellitus with kidney complications
- E11.3 Type 2 diabetes mellitus with ophthalmic complications
- E11.4 Type 2 diabetes mellitus with neurological complications
- E11.5 Type 2 diabetes mellitus with circulatory complications
- E11.6 Type 2 diabetes mellitus with other specified complications
- E11.8 Type 2 diabetes mellitus with unspecified complications
- E11.9 Type 2 diabetes mellitus without complications
Related indications (MeSH) (1)
Diabetes Mellitus, Type 21169 drugs (347 approved, 822 experimental)
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.